Shopping Cart 0
Cart Subtotal
AED 0

Propanc Biopharma Inc (PPCB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Propanc Biopharma Inc (Propanc), formerly Propanc Health Group Corp, is a clinical stage biopharmaceutical company, which manufactures products for the treat of metastatic, pancreatic, ovarian and colorectal cancers. The company's lead product candidate, PRP, a once-a-day intravenous formulation of two pancreatic proenzymes, trypsinogen and chymotrypsinogen, helps block the recurrence of tumor and metastasis. PRP curtails tumor growth by curbing cancer cell migration and suppressing tumor blood vessel formation, and ultimately causing cell death. The company works in collaboration with other research universities and companies including University of Grenada, Universidad de Jaen, University of Bath and vivoPharm Pty Ltd for the research and development of PRP. Propanc is headquartered in Melbourne, Victoria, Australia.

Propanc Biopharma Inc (PPCB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Propanc Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Propanc Biopharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Propanc Health Raises USD 0.03 Million In Venture Financing 12

Partnerships 13

Propanc Biopharma Enters into Research Agreement with University of Jaen 13

Propanc Biopharma Enters into Research Partnership with Jaen University 14

Equity Offering 15

Propanc Health to Raise Funds through Public Offering of Shares and Warrants 15

Propanc Biopharma Raises USD0.2 Million in Private Placement of Shares, up on Exercise of Warrants 16

Propanc Biopharma Raises USD0.3 Million in Private Placement of Shares, up on Exercise of Warrants 17

Propanc Health to Raise USD0.02 Million in Private Placement of Shares 18

Propanc Health to Raise Funds through Private Placement of Shares 19

Propanc Health Raises Funds through Private Placement of Shares 20

Propanc Health to Raise USD5 Million in Private Placement of Shares 21

Propanc Health Announces Private Placement of Shares For USD 1.5 Million 22

Debt Offering 23

Propanc Biopharma Raises USD0.4 Million in Private Placement of Debt Securities 23

Propanc Biopharma Raises USD6.31 Million in Debt Offering of Notes 24

Propanc Biopharma Raises USD0.22 Million in Private Placement of 8% Notes 25

Propanc Biopharma Raises USD0.23 Million in Private Placement of 8% Notes 26

Propanc Biopharma Raises USD0.17 Million in Private Placement of 8% Convertible Notes 27

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Convertible Notes 28

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Notes 29

Propanc Health Raises USD4 Million in Private Placement of Debenture 30

Propanc Biopharma Inc-Key Competitors 31

Propanc Biopharma Inc-Key Employees 32

Propanc Biopharma Inc-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Corporate Communications 34

Jan 10, 2018: Propanc Biopharma Engages Alan Morell of Creative Management Partners as Senior Strategic Advisor to CEO and Board of Directors 34

Product News 35

Dec 04, 2017: Propanc Biopharma Advances towards GMP Manufacture of PRP for Human Trials 35

05/19/2017: Propanc Biopharma Highlights PRP's Potential to Reprogram Cancer Stem Cells 36

05/02/2017: Propanc Biopharma Provides Update on Investigational Medicinal Product Manufacture of PRP for First-In-Human Studies 37

02/14/2017: Propanc Successfully Completes Low Dose Group for GLP-Compliant 28-Day Repeat-Dose Toxicity Study 38

01/04/2017: Propanc Provides Shareholder Update and Forecast for 2017 39

Clinical Trials 41

Apr 27, 2017: Propanc Successfully Completes 28-Day Repeat-Dose Toxicity Study for PRP 41

Other Significant Developments 42

Feb 12, 2018: Propanc Biopharma Provides Shareholder Update and Goals for 2018 42

Mar 31, 2017: Propanc Announces Name Change to Propanc Biopharma 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Propanc Biopharma Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Propanc Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Propanc Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Propanc Biopharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Propanc Health Raises USD 0.03 Million In Venture Financing 12

Propanc Biopharma Enters into Research Agreement with University of Jaen 13

Propanc Biopharma Enters into Research Partnership with Jaen University 14

Propanc Health to Raise Funds through Public Offering of Shares and Warrants 15

Propanc Biopharma Raises USD0.2 Million in Private Placement of Shares, up on Exercise of Warrants 16

Propanc Biopharma Raises USD0.3 Million in Private Placement of Shares, up on Exercise of Warrants 17

Propanc Health to Raise USD0.02 Million in Private Placement of Shares 18

Propanc Health to Raise Funds through Private Placement of Shares 19

Propanc Health Raises Funds through Private Placement of Shares 20

Propanc Health to Raise USD5 Million in Private Placement of Shares 21

Propanc Health Announces Private Placement of Shares For USD 1.5 Million 22

Propanc Biopharma Raises USD0.4 Million in Private Placement of Debt Securities 23

Propanc Biopharma Raises USD6.31 Million in Debt Offering of Notes 24

Propanc Biopharma Raises USD0.22 Million in Private Placement of 8% Notes 25

Propanc Biopharma Raises USD0.23 Million in Private Placement of 8% Notes 26

Propanc Biopharma Raises USD0.17 Million in Private Placement of 8% Convertible Notes 27

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Convertible Notes 28

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Notes 29

Propanc Health Raises USD4 Million in Private Placement of Debenture 30

Propanc Biopharma Inc, Key Competitors 31

Propanc Biopharma Inc, Key Employees 32

Propanc Biopharma Inc, Subsidiaries 33

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Propanc Biopharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Propanc Biopharma Inc (Propanc), formerly Propanc Health Group Corp, is a clinical stage biopharmaceutical company, which manufactures products for the treat of metastatic, pancreatic, ovarian and colorectal cancers. The company's lead product candidate, PRP, a once-a-day intravenous formulation of two pancreatic proenzymes, trypsinogen and chymotrypsinogen, helps block the recurrence of tumor and metastasis. PRP curtails tumor growth by curbing cancer cell migration and suppressing tumor blood vessel formation, and ultimately causing cell death. The company works in collaboration with other research universities and companies including University of Grenada, Universidad de Jaen, University of Bath and vivoPharm Pty Ltd for the research and development of PRP. Propanc is headquartered in Melbourne, Victoria, Australia.

Propanc Biopharma Inc (PPCB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Propanc Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Propanc Biopharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Propanc Health Raises USD 0.03 Million In Venture Financing 12

Partnerships 13

Propanc Biopharma Enters into Research Agreement with University of Jaen 13

Propanc Biopharma Enters into Research Partnership with Jaen University 14

Equity Offering 15

Propanc Health to Raise Funds through Public Offering of Shares and Warrants 15

Propanc Biopharma Raises USD0.2 Million in Private Placement of Shares, up on Exercise of Warrants 16

Propanc Biopharma Raises USD0.3 Million in Private Placement of Shares, up on Exercise of Warrants 17

Propanc Health to Raise USD0.02 Million in Private Placement of Shares 18

Propanc Health to Raise Funds through Private Placement of Shares 19

Propanc Health Raises Funds through Private Placement of Shares 20

Propanc Health to Raise USD5 Million in Private Placement of Shares 21

Propanc Health Announces Private Placement of Shares For USD 1.5 Million 22

Debt Offering 23

Propanc Biopharma Raises USD0.4 Million in Private Placement of Debt Securities 23

Propanc Biopharma Raises USD6.31 Million in Debt Offering of Notes 24

Propanc Biopharma Raises USD0.22 Million in Private Placement of 8% Notes 25

Propanc Biopharma Raises USD0.23 Million in Private Placement of 8% Notes 26

Propanc Biopharma Raises USD0.17 Million in Private Placement of 8% Convertible Notes 27

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Convertible Notes 28

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Notes 29

Propanc Health Raises USD4 Million in Private Placement of Debenture 30

Propanc Biopharma Inc-Key Competitors 31

Propanc Biopharma Inc-Key Employees 32

Propanc Biopharma Inc-Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 34

Corporate Communications 34

Jan 10, 2018: Propanc Biopharma Engages Alan Morell of Creative Management Partners as Senior Strategic Advisor to CEO and Board of Directors 34

Product News 35

Dec 04, 2017: Propanc Biopharma Advances towards GMP Manufacture of PRP for Human Trials 35

05/19/2017: Propanc Biopharma Highlights PRP's Potential to Reprogram Cancer Stem Cells 36

05/02/2017: Propanc Biopharma Provides Update on Investigational Medicinal Product Manufacture of PRP for First-In-Human Studies 37

02/14/2017: Propanc Successfully Completes Low Dose Group for GLP-Compliant 28-Day Repeat-Dose Toxicity Study 38

01/04/2017: Propanc Provides Shareholder Update and Forecast for 2017 39

Clinical Trials 41

Apr 27, 2017: Propanc Successfully Completes 28-Day Repeat-Dose Toxicity Study for PRP 41

Other Significant Developments 42

Feb 12, 2018: Propanc Biopharma Provides Shareholder Update and Goals for 2018 42

Mar 31, 2017: Propanc Announces Name Change to Propanc Biopharma 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Propanc Biopharma Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Propanc Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Propanc Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Propanc Biopharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

Propanc Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Propanc Health Raises USD 0.03 Million In Venture Financing 12

Propanc Biopharma Enters into Research Agreement with University of Jaen 13

Propanc Biopharma Enters into Research Partnership with Jaen University 14

Propanc Health to Raise Funds through Public Offering of Shares and Warrants 15

Propanc Biopharma Raises USD0.2 Million in Private Placement of Shares, up on Exercise of Warrants 16

Propanc Biopharma Raises USD0.3 Million in Private Placement of Shares, up on Exercise of Warrants 17

Propanc Health to Raise USD0.02 Million in Private Placement of Shares 18

Propanc Health to Raise Funds through Private Placement of Shares 19

Propanc Health Raises Funds through Private Placement of Shares 20

Propanc Health to Raise USD5 Million in Private Placement of Shares 21

Propanc Health Announces Private Placement of Shares For USD 1.5 Million 22

Propanc Biopharma Raises USD0.4 Million in Private Placement of Debt Securities 23

Propanc Biopharma Raises USD6.31 Million in Debt Offering of Notes 24

Propanc Biopharma Raises USD0.22 Million in Private Placement of 8% Notes 25

Propanc Biopharma Raises USD0.23 Million in Private Placement of 8% Notes 26

Propanc Biopharma Raises USD0.17 Million in Private Placement of 8% Convertible Notes 27

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Convertible Notes 28

Propanc Biopharma Raises USD0.1 Million in Private Placement of 8% Notes 29

Propanc Health Raises USD4 Million in Private Placement of Debenture 30

Propanc Biopharma Inc, Key Competitors 31

Propanc Biopharma Inc, Key Employees 32

Propanc Biopharma Inc, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Propanc Biopharma Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.